Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 30, 2020

SELL
$0.65 - $1.68 $29,250 - $75,600
-45,000 Closed
0 $0
Q3 2019

Nov 01, 2019

BUY
$1.06 - $1.87 $5,300 - $9,350
5,000 Added 12.5%
45,000 $48,000
Q1 2019

Apr 24, 2019

BUY
$1.65 - $3.29 $8,250 - $16,450
5,000 Added 14.29%
40,000 $66,000
Q4 2018

Feb 01, 2019

BUY
$1.5 - $5.4 $52,500 - $189,000
35,000 New
35,000 $53,000

About ENDRA Life Sciences Inc.


  • Ticker NDRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 63,174,500
  • Market Cap $398M
  • Description
  • ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperat...
More about NDRA
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.